Related Experiment Videos
Prediction of cerebral palsy in high-risk neonates: a technetium-99m-HMPAO SPECT study
R Denays1, T VanPachterbeke, V Toppet
1Department of Neurology, St-Pierre Hospital, Free University of Brussels, Belgium.
Insights
Technetium-99m-labeled hexamethylpropylene amine oxime (99mTc-HMPAO) brain SPECT can help predict neurological handicaps in high-risk infants. This advanced imaging technique is most useful when conventional tests yield inconclusive results for neonates.
Area of Science:
- Pediatric Neurology
- Diagnostic Imaging
- Neonatal Care
Background:
- Diagnosing brain damage and predicting neurological handicaps in infants with prenatal or perinatal injury is challenging using clinical exams and conventional tests like EEG and ultrasound.
- Identifying high-risk neonates requiring early intervention for potential neurological deficits is crucial for improving outcomes.
Purpose of the Study:
- To investigate the predictive value of 99mTc-HMPAO brain SPECT in identifying neurological handicaps in high-risk neonates within the first few weeks of life.
- To compare the efficacy of 99mTc-HMPAO brain SPECT with conventional diagnostic methods in predicting adverse neurological outcomes.
Main Methods:
- A study involving high-risk neonates where 99mTc-HMPAO brain SPECT was performed in the early weeks of life.
- Analysis of regional cerebral blood flow (rCBF) distribution, specifically antero-posterior patterns and right-left asymmetries, in relation to infant outcomes.
- Comparison of SPECT findings with clinical examination, electroencephalogram (EEG), and cranial ultrasonography results.
Main Results:
- Right-left asymmetries in tracer uptake showed no predictive value for neurological handicaps.
- An altered antero-posterior rCBF distribution was observed in 7/10 neonates with adverse outcomes (death or major neurological sequelae).
- SPECT provided additional predictive information primarily in cases where conventional investigations yielded incongruent results, identifying 4/6 neonates with major neurological sequelae.
Conclusions:
- 99mTc-HMPAO brain SPECT can be a valuable tool for predicting major neurological handicaps in high-risk neonates when used judiciously.
- Due to its invasive nature, SPECT should not be routinely administered to all high-risk neonates; it is best indicated when conventional noninvasive tests produce conflicting results.
- The antero-posterior rCBF pattern on SPECT appears more informative than right-left asymmetries for predicting adverse outcomes in this population.
Abstract:
In infants who have experienced prenatal or perinatal injury, it is often difficult, on the basis of clinical examination and conventional investigations (electroencephalogram, cranial ultrasound scan), to diagnose those with brain damage and to predict the type and the severity of subsequent neurological handicaps. We investigated the predictive value of 99mTc-HMPAO brain SPECT performed in the first weeks of life in high-risk neonates. Right-left asymmetries in tracer uptake had no predictive value, regardless of their localization or severity. On the other hand, a change in antero-posterior rCBF distribution was found in 7/10 of neonates with adverse outcome (death, major neurological sequelae) and in none of the 78 neonates with no major motor neurological sequelae. Compared to conventional investigations, 99mTc-HMPAO brain SPECT did not provide additional predictive information when neurological examination, electroencephalogram and cranial ultrasonography were all normal or all abnormal. Conversely, in the 30 patients with anomalies on one or two of the above investigations, SPECT showed an abnormal antero-posterior pattern in 4/6 neonates with major neurological sequelae and no change in the antero-posterior rCBF distribution in the 24 infants who developed normally. In conclusion, our results suggest that 99mTc-HMPAO brain SPECT, when performed in the first weeks of life, can be useful in high-risk neonates to predict occurrence of major neurological handicaps. Because of the relative invasive character of HMPAO scan in neonates and the overall accuracy of the noninvasive tests, radionuclide examination should not be performed in every high-risk neonate. According to our results, 99mTc-HMPAO brain SPECT might be indicated in those children where noncongruent results were obtained with conventional studies.